“Increased Spinal IL-16-CD4 Signaling Contributes to Inflammatory Pain: Implications for Treatment”

https://pubmed.ncbi.nlm.nih.gov/38113689

The study suggests that increased spinal IL-16-CD4 signaling contributes to inflammatory pain by activating microglia and astrocytes, positioning IL-16 as a promising target for inflammatory pain treatment.